anti-VEGF-A aptamer (Vitrisa Therapeutics)

N/A

Report date: 2025/03/14 16:29:19

Base Information

Drug Nameanti-VEGF-A aptamer (Vitrisa Therapeutics)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionVascular endothelial growth factor receptor antagonists
TargetsVascular endothelial growth factor receptor
Therapy Area/IndicationsRetinal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVitrisa Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesVitrisa Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsRetinal Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A